WO2003042409A3 - Mutation de la ligne germinale dans le promoteur genique de la caderine e et methode de diagnostic d'identification d'une sensibilite accrue a la carcinome gastrique - Google Patents
Mutation de la ligne germinale dans le promoteur genique de la caderine e et methode de diagnostic d'identification d'une sensibilite accrue a la carcinome gastrique Download PDFInfo
- Publication number
- WO2003042409A3 WO2003042409A3 PCT/IT2002/000729 IT0200729W WO03042409A3 WO 2003042409 A3 WO2003042409 A3 WO 2003042409A3 IT 0200729 W IT0200729 W IT 0200729W WO 03042409 A3 WO03042409 A3 WO 03042409A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- caderine
- promoter
- gastric carcinoma
- finding
- sought
- Prior art date
Links
- 206010017758 gastric cancer Diseases 0.000 title abstract 2
- 208000010749 gastric carcinoma Diseases 0.000 title abstract 2
- 201000000498 stomach carcinoma Diseases 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 210000004602 germ cell Anatomy 0.000 title 1
- 230000035772 mutation Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 230000003321 amplification Effects 0.000 abstract 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229930024421 Adenine Natural products 0.000 abstract 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- 206010071602 Genetic polymorphism Diseases 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 229960000643 adenine Drugs 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229940104302 cytosine Drugs 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002358976A AU2002358976A1 (en) | 2001-11-16 | 2002-11-15 | Germ line mutation in the promoter of e-caderine and diagnostic method for finding a greater susceptibility to gastric carcinoma |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001TO001077A ITTO20011077A1 (it) | 2001-11-16 | 2001-11-16 | Mutazioni della linea germinale nel promotore del gene della e-caderina e metodo di diagnosi per individuare una maggiore suscettibilita' a |
ITTO01A001077 | 2001-11-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003042409A2 WO2003042409A2 (fr) | 2003-05-22 |
WO2003042409A3 true WO2003042409A3 (fr) | 2003-12-18 |
WO2003042409A8 WO2003042409A8 (fr) | 2004-04-08 |
Family
ID=11459301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT2002/000729 WO2003042409A2 (fr) | 2001-11-16 | 2002-11-15 | Mutation de la ligne germinale dans le promoteur genique de la caderine e et methode de diagnostic d'identification d'une sensibilite accrue a la carcinome gastrique |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002358976A1 (fr) |
IT (1) | ITTO20011077A1 (fr) |
WO (1) | WO2003042409A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101106014B1 (ko) * | 2008-12-04 | 2012-01-17 | 차의과학대학교 산학협력단 | 1번 염색체로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 분석방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020168A2 (fr) * | 1997-10-17 | 1999-04-29 | University Of Otago | Mutations de lignee germinale dans le gene de la e-cadherine et procede de detection d'une predisposition au cancer |
-
2001
- 2001-11-16 IT IT2001TO001077A patent/ITTO20011077A1/it unknown
-
2002
- 2002-11-15 WO PCT/IT2002/000729 patent/WO2003042409A2/fr not_active Application Discontinuation
- 2002-11-15 AU AU2002358976A patent/AU2002358976A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020168A2 (fr) * | 1997-10-17 | 1999-04-29 | University Of Otago | Mutations de lignee germinale dans le gene de la e-cadherine et procede de detection d'une predisposition au cancer |
Non-Patent Citations (14)
Title |
---|
BECKER K.-F. ET AL.: "SINGLE NUCLEOTIDE POLYMORPHISMS IN THE HUMAN E-CADHERIN GENE", HUMAN GENETICS, vol. 96, no. 6, 1995, pages 739 - 740, XP000979504 * |
BERX G. ET AL.: "E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 14, no. 24, 1995, pages 6107 - 6115, XP002204447, ISSN: 0261-4189 * |
BERX GEERT ET AL: "Mutations of the human E-cadherin (CDH1) gene.", HUMAN MUTATION, vol. 12, no. 4, 1998, pages 226 - 237, XP009017827, ISSN: 1059-7794 * |
BUSSEMAKERS M.J.G. ET AL.: "TRANSCRIPTIONAL REGULATION OF THE HUMAN E-CADHERIN GENE IN HUMAN PROSTATE CANCER CELL LINES: CHARACTERIZATION OF THE E-CADHERIN GENE PROMOTOR", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 203, no. 2, 15 September 1994 (1994-09-15), pages 1284 - 1290, XP002941271, ISSN: 0006-291X * |
DEBRUYNE P ET AL: "The role of the E-cadherin/catenin complex in gastrointestinal cancer.", ACTA GASTRO-ENTEROLOGICA BELGICA. BELGIUM 1999 OCT-DEC, vol. 62, no. 4, October 1999 (1999-10-01), pages 393 - 402, XP009017828, ISSN: 0001-5644 * |
GUILFORD P. ET AL.: "E-cadherin germline mutations in familial gastric cancer.", NATURE (LONDON), vol. 392, no. 6674, 26 March 1998 (1998-03-26), pages 402 - 405, XP002255108, ISSN: 0028-0836 * |
GUILFORD P.: "E-cadherin downregulation in cancer: Fuel on the fire?", MOLECULAR MEDICINE TODAY, vol. 5, no. 4, April 1999 (1999-04-01), pages 172 - 177, XP001155310, ISSN: 1357-4310 * |
HUMAR B. ET AL.: "Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.", ONCOGENE, vol. 21, no. 53, 21 November 2002 (2002-11-21), pages 8192 - 8195, XP002255113, ISSN: 0950-9232 * |
HUMAR B. ET AL.: "Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.", HUMAN MUTATION, vol. 19, no. 5, 2002, 2002, pages 518 - 525, XP009017719, ISSN: 1059-7794 * |
IKONEN T. ET AL.: "Association of E-cadherin germ-line alterations with prostate cancer.", CLINICAL CANCER RESEARCH, vol. 7, no. 11, November 2001 (2001-11-01), pages 3465 - 3471, XP002255110, ISSN: 1078-0432 * |
LI L.-C. ET AL.: "A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.", CANCER RESEARCH, vol. 60, no. 4, 15 February 2000 (2000-02-15), pages 873 - 876, XP002255107, ISSN: 0008-5472 * |
MATSUMURA T. ET AL.: "Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.", CLINICAL CANCER RESEARCH, vol. 7, no. 3, March 2001 (2001-03-01), pages 594 - 599, XP002255111, ISSN: 1078-0432 * |
RICHARDS F.M. ET AL.: "Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.", HUMAN MOLECULAR GENETICS, vol. 8, no. 4, April 1999 (1999-04-01), pages 607 - 610, XP002255109, ISSN: 0964-6906 * |
WU M.-S. ET AL.: "Association of the -160 C->A promoter polymorphism of E-cadherin gene with gastric carcinoma risk.", CANCER, vol. 94, no. 5, 1 March 2002 (2002-03-01), pages 1443 - 1448, XP002255112, ISSN: 0008-543X * |
Also Published As
Publication number | Publication date |
---|---|
ITTO20011077A1 (it) | 2003-05-16 |
WO2003042409A8 (fr) | 2004-04-08 |
AU2002358976A1 (en) | 2003-05-26 |
WO2003042409A2 (fr) | 2003-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2400538C2 (ru) | Олигонуклеотид с двойственной специфичностью и способы, в которых он используется | |
JP5307538B2 (ja) | Ugt1a1遺伝子増幅用プライマーセット、それを含むugt1a1遺伝子増幅用試薬およびその用途 | |
CA2528577A1 (fr) | Methodes et compositions utiles pour l'amplification et le genotypage du genome tout entier | |
WO2002006531A3 (fr) | Sondes d'acides nucleiques a structure en epingle a cheveux et utilisations associees | |
PL1730311T3 (pl) | Sposób genotypowania antygenów krwinkowych oraz zestaw odpowiedni do genotypowania antygenów krwinkowych | |
JP2010535507A5 (fr) | ||
WO2008147930A3 (fr) | Méthodes et kits de liaison de séquences polymorphes à des mutations de répétitions étendues | |
CA2414782A1 (fr) | Intron associe a la dystrophie myotonique de type 2 et procedes d'utilisation | |
JP2011505812A5 (fr) | ||
WO2009064973A4 (fr) | Trousses de diagnostic pour choix d'une thérapie en cas de mort subite par arrêt cardiaque (scd) ou d'arrêt cardiaque subit (sca) | |
JPWO2008066162A1 (ja) | Cyp2c19遺伝子増幅用プライマーセット、それを含むcyp2c19遺伝子増幅用試薬およびその用途 | |
JP2005518217A5 (fr) | ||
WO2011062258A1 (fr) | Ensemble d'amorces pour l'amplification du gène mthfr, réactif d'amplification du gène mthfr le comprenant et son utilisation | |
EP2025764B1 (fr) | Sonde pour la détection d'une mutation dans le gène abl et son utilisation | |
JP2010035532A (ja) | アレル特異的pcr法 | |
JP2013074888A (ja) | IL28B(rs8099917)とITPA(rs1127354)の変異を検出する方法 | |
JP5258760B2 (ja) | メチル化核酸又は非メチル化核酸を増幅する方法 | |
WO2003042409A8 (fr) | Mutation de la ligne germinale dans le promoteur genique de la caderine e et methode de diagnostic d'identification d'une sensibilite accrue a la carcinome gastrique | |
JPWO2011077990A1 (ja) | c−kit遺伝子の多型検出用プローブおよびその用途 | |
WO2008066161A1 (fr) | Jeu d'amorces pour l'amplification du gène nat2, réactif pour l'amplification du gène nat2 comprenant ledit jeu d'amorces et utilisation du réactif | |
EP2784165A1 (fr) | Procédé pour la détection d'une prédisposition génétique au cancer de la prostate | |
WO2000055361A3 (fr) | Procede d'identification d'organismes par analyse genetique comparative, amorceur et sondes d'hybridation utilises pour la mise en oeuvre de ce procede | |
KR101899235B1 (ko) | 한국인의 주의력결핍 과잉행동장애 진단을 위한 프라이머 세트, 이를 포함하는 진단용 키트, 및 이를 이용한 한국인의 주의력결핍 과잉행동장애 위험도 예측 방법 | |
JP2005245272A (ja) | アルコール脱水素酵素遺伝子多型の簡易検出方法および検出用試薬 | |
WO2003023063A1 (fr) | Methode d'estimation du risque d'apparition de diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |